Related Experiment Video
Updated: Jun 4, 2025

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Insight into a multifunctional potassium channel Kv1.3 and its novel implication in chronic kidney disease
Zac Dragan1, Carol A Pollock1, Chunling Huang1
1Kolling Institute, Sydney Medical School Northern, Faculty of Medicine and Health, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Abstract:
Chronic kidney disease (CKD), a global public health problem, causes substantial morbidity and mortality worldwide. Innovative therapeutic strategies to mitigate the progression of CKD are needed due to the limitations of existing treatments. Kv1.3, a voltage-gated potassium ion channel, plays a crucial role in multiple biological processes, including cell proliferation, apoptosis, energy homeostasis, and migration. Inhibition of the Kv1.3 channels has shown beneficial effects in the therapy of a wide range of human diseases such as cancer, autoimmune and neuroinflammatory diseases. Increasing evidence reveals a close link between Kv1.3 and CKD. This review summarises the most recent insights into the physiological functions of the Kv1.3 channel and its pharmacological modulators. Furthermore, the therapeutic potential of targeting Kv1.3 for CKD is also discussed. Collectively, these studies suggested that Kv1.3 channels may serve as a novel target for CKD therapy.
Insights
Targeting the Kv1.3 channel, crucial in cell processes, shows promise for treating chronic kidney disease (CKD). This review explores Kv1.3
Area of Science:
- Nephrology
- Molecular Biology
- Pharmacology
Background:
- Chronic kidney disease (CKD) is a significant global health issue with limited treatment options.
- The voltage-gated potassium channel Kv1.3 is implicated in various cellular functions and diseases.
- Emerging evidence links Kv1.3 channels to the pathogenesis of CKD.
Purpose of the Study:
- To review the physiological roles of the Kv1.3 channel.
- To discuss pharmacological modulators of Kv1.3.
- To evaluate the therapeutic potential of targeting Kv1.3 for CKD treatment.
Main Methods:
- Literature review of recent studies on Kv1.3.
- Analysis of Kv1.3's role in cellular processes relevant to CKD.
- Examination of existing research on Kv1.3 inhibitors in other diseases.
Main Results:
- Kv1.3 channels are involved in cell proliferation, apoptosis, energy homeostasis, and migration.
- Inhibition of Kv1.3 has therapeutic benefits in cancer, autoimmune, and neuroinflammatory diseases.
- Kv1.3's link to CKD suggests its involvement in kidney disease progression.
Conclusions:
- Kv1.3 channels play a significant role in biological processes relevant to CKD.
- Pharmacological targeting of Kv1.3 presents a potential novel therapeutic strategy for CKD.
- Further research into Kv1.3 modulators could lead to innovative CKD treatments.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
Nephrons
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
The Role of Ion Channels in Neuronal Computation
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential....

